Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16463252 | 1.00 | HPGD (0.41) | HPGDHTTKMT2AMEN1RAB9A | |
| SCHEMBL17085396 | 0.83 | ATM (0.48) | HPGDHTTKMT2AMEN1LMNA | |
| SCHEMBL5930119 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL21979446 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL2437801 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL23092514 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL495878 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL2438588 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL3508763 | 0.83 | NPC1 (0.44) | KMT2ARAB9ANPC1CYP1A2 | |
| SCHEMBL14895451 | 0.79 | CYP1A2 (0.37) | HPGDHTTKMT2AMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2903974-B1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INC UNDER THE REGISTRATION OF SOCIETIES ACT AC (IN) | 2016-11-23 | — | — | EP | claimed |
| EP-2903974-A1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | Council of Scientific & Industrial Research An Indian registered body incorporated under the Registration of Societies Act (Act XXI of 1860) (IN) | 2015-08-12 | — | — | EP | claimed |
| WO-2014057500-A1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED (IN) | 2014-04-17 | — | — | WO | claimed |
| EP-2903974-B1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | COUNCIL OF SCIENT & IND RES AN INDIAN REGISTERED BODY INC UNDER THE REGISTRATION OF SOCIETIES ACT AC (IN) | 2016-11-23 | — | — | EP | disclosed |
| US-9266854-B2 | One step process for synthesis of cyclic carbonates | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-02-23 | — | — | US | disclosed |
| US-20150259318-A1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259318-A1 | ONE STEP PROCESS FOR SYNTHESIS OF CYCLIC CARBONATES | CDY1; CDY1B, CA4, CCNY | HPGD 1683/4885HTT 4737/4885KMT2A 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.